Finally, we find that human breast cancers with mutations in Polq synthetic lethal (PolqSL) genes identified in our CRISPR screen may be addicted to Pol θ, based on increased expression of TMEJ-associated genomic scars. This evidence concerns the gene POLQ and breast carcinoma.